Literature DB >> 19208600

Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis.

Alessandra Magnani1, Angela Pistorio, Silvia Magni-Manzoni, Alessandra Falcone, Giuseppina Lombardini, Marcia Bandeira, Federica Rossi, Ilaria Sala, Alberto Martini, Angelo Ravelli.   

Abstract

OBJECTIVE: To investigate whether the achievement of inactive disease in the first 5 years predicts a more favorable outcome of children with juvenile idiopathic arthritis (JIA).
METHODS: We reviewed clinical charts of 123 patients who started taking methotrexate, were followed for at least 5 years, and received a yearly assessment in the first 5 years. At each yearly visit, the presence of inactive disease was assessed. Patients were divided into 3 groups: (1) patients who never reached inactive disease; (2) patients who reached inactive disease in only 1 visit; and (3) patients who reached inactive disease in > or = 2 visits. Outcome was evaluated after 6 to 18 years (median 7.1 yrs) by assessing the following clinical measures: restricted joint count, Childhood Health Assessment Questionnaire (CHAQ), Juvenile Arthritis Damage Index (JADI), and Poznanski score of radiographic damage.
RESULTS: In the first 5 years, 62 patients (50.4%) were noted to have active disease at their yearly visit, 40 patients (32.5%) were noted to have inactive disease only once, and 21 patients (17.1%) were noted to have inactive disease in > or = 2 visits. Patients who achieved inactive disease 1 or more times had lower restricted joint count (p = 0.007) and JADI-Articular score (p = 0.004) at last followup visit than those who never reached such a state. A similar trend, although not significant, was observed for CHAQ and Poznanski score of radiographic damage.
CONCLUSION: Attainment of the state of inactive disease at least once in the first 5 years was found to be associated with less longterm joint damage and with a trend toward less functional impairment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208600     DOI: 10.3899/jrheum.080560

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

Review 1.  The clinical spectrum of juvenile idiopathic arthritis in a large urban population.

Authors:  Melissa S Tesher; Karen B Onel
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

2.  What does it mean to grow up with juvenile idiopathic arthritis? A qualitative study on the perspectives of patients.

Authors:  Leen Eyckmans; Deborah Hilderson; Rene Westhovens; Carine Wouters; Philip Moons
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

Review 3.  Remission in juvenile idiopathic arthritis: current facts.

Authors:  Susan Shenoi; Carol A Wallace
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

4.  Do patients with juvenile idiopathic arthritis in clinical remission have evidence of persistent inflammation on 3T magnetic resonance imaging?

Authors:  Amanda Brown; Raphael Hirsch; Tal Laor; Michael J Hannon; Marc C Levesque; Terence Starz; Kimberly Francis; C Kent Kwoh
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

5.  Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis.

Authors:  Bin Huang; Tingting Qiu; Chen Chen; Yin Zhang; Michael Seid; Dan Lovell; Hermine I Brunner; Esi M Morgan
Journal:  RMD Open       Date:  2020-01

Review 6.  Clinical Outcome and Long-term Remission in JIA.

Authors:  Mia Glerup; T Herlin; M Twilt
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

7.  Sustained rheumatoid arthritis remission is uncommon in clinical practice.

Authors:  Femke H M Prince; Vivian P Bykerk; Nancy A Shadick; Bing Lu; Jing Cui; Michelle Frits; Christine K Iannaccone; Michael E Weinblatt; Daniel H Solomon
Journal:  Arthritis Res Ther       Date:  2012-03-19       Impact factor: 5.156

8.  The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort.

Authors:  Claudia Sengler; Jens Klotsche; Martina Niewerth; Ina Liedmann; Dirk Föll; Arnd Heiligenhaus; Gerd Ganser; Gerd Horneff; Johannes-Peter Haas; Kirsten Minden
Journal:  RMD Open       Date:  2015-12-08

Review 9.  Clinical outcome measures in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Gabriella Giancane; Benedetta Schiappapietra; Sergio Davì; Serena Calandra; Stefano Lanni; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-18       Impact factor: 3.054

Review 10.  Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis.

Authors:  Gerd Horneff; Ariane Klein; Gerd Ganser; Michaela Sailer-Höck; Annette Günther; Ivan Foeldvari; Frank Weller-Heinemann
Journal:  Pediatr Rheumatol Online J       Date:  2017-11-07       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.